US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 13.930
  • +0.460+3.41%
Close Dec 13 16:00 ET
  • 13.500
  • -0.430-3.09%
Post 18:06 ET
1.19BMarket Cap-3.83P/E (TTM)

Syndax Pharmaceuticals Key Stats

Syndax Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 5, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
8.40M
12.50M
+4.10M
Beat Est.
--
--
+48.83%
EPS
-1.03
-0.98
+0.05
Beat Est.
-40.72%
-34.25%
+4.59%
Strong Buy

Dec 5, 2024

Syndax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.142M--
--2024/Q4-- / 115.892M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.142M--
--2024/Q4-- / 115.892M--
Nov 5, 20242024/Q312.500M / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Syndax Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 5, 2024

Strong Buy

  • Buy

    92.86%
  • Hold

    7.14%
  • Sell

    0.00%

Price Target

No Data